MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1086/423851

Медицинская библиотека · The Journal of infectious diseases · 2004

Clinical and immune responses after revaccination of israeli adults with the Lister strain of vaccinia virus.

Orr Nadav, Forman Moshe, Marcus Hadar, Lustig Shlomo, Paran Nir, Grotto Itamar, Klement Eyal, Yehezkelli Yoav, Robin Guy, Reuveny Shaul, Shafferman Avigdor, Cohen Dani, Vaccinia Study Group, Medical Corps, Israel Defense Force, Vaccinia Study Group, Israel Institute for Biological Research

СтатьяПеревод в очереди

Аннотация

BACKGROUND

During the winter of 2002-2003, the Israeli health authorities launched a campaign to vaccinate first responders against smallpox.

METHODS

In an open study, 159 healthy, preimmunized adults, 24-52 years old, who participated in the campaign were vaccinated with the Lister strain of vaccinia virus by the multipuncture technique. The safety, immunogenicity, and reactogenicity of the vaccine were assessed.

RESULTS

Successful vaccination rates were 61% and 56%, on the basis of clinical take and seroconversion, respectively. Adverse events among the vaccinees were minor. Seventy-nine (88%) of the 90 vaccinees with clinical take also seroconverted ( kappa =0.779). The level of preexisting antibodies inversely correlated with the rates of clinical take and seroconversion (P</=.0098). In the group of vaccinees with the lowest preexisting levels of antibodies, 89% and 86% developed clinical take or seroconverted, respectively. The time since last vaccination was significantly associated with the rates of clinical take and seroconversion (P</=0.001).

CONCLUSIONS

These rates of successful vaccination in previously immunized individuals are consistent with the historical experience of use of this vaccine in Israel. The rate of occurrence and the severity of local and other reactions in the vaccinees were within the expected range. Levels of preexisting antibodies and the time since last vaccination played a major role in determining success rates.

Для цитирования: Orr Nadav, Forman Moshe, Marcus Hadar, Lustig Shlomo, Paran Nir, Grotto Itamar, Klement Eyal, Yehezkelli Yoav, Robin Guy, Reuveny Shaul, Shafferman Avigdor, Cohen Dani, Vaccinia Study Group, Medical Corps, Israel Defense Force, Vaccinia Study Group, Israel Institute for Biological Research. Clinical and immune responses after revaccination of israeli adults with the Lister strain of vaccinia virus.. The Journal of infectious diseases. 2004. DOI: 10.1086/423851.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.